Sarepta Therapeutics (SRPT) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 106.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.04% |
| Dec 31, 2025 | -35.21% |
| Sep 30, 2025 | 104.47% |
| Jun 30, 2025 | 33.10% |
| Mar 31, 2025 | -43.63% |
| Dec 31, 2024 | 157.45% |
| Sep 30, 2024 | -63.49% |
| Jun 30, 2024 | -54.97% |
| Mar 31, 2024 | -50.98% |
| Dec 31, 2023 | -55.68% |
| Sep 30, 2023 | -47.82% |
| Jun 30, 2023 | -1.92% |
| Mar 31, 2023 | -29.36% |
| Dec 31, 2022 | -54.31% |
| Sep 30, 2022 | -35.05% |
| Jun 30, 2022 | -48.83% |
| Mar 31, 2022 | -16.73% |
| Dec 31, 2021 | 40.81% |
| Sep 30, 2021 | 8.44% |
| Jun 30, 2021 | 3.49% |
| Mar 31, 2021 | -16.01% |
| Dec 31, 2020 | 79.94% |
| Sep 30, 2020 | 103.45% |
| Jun 30, 2020 | 102.82% |
| Mar 31, 2020 | 140.95% |
| Dec 31, 2019 | 125.19% |
| Sep 30, 2019 | 245.65% |
| Jun 30, 2019 | 97.04% |
| Mar 31, 2019 | 31.40% |
| Dec 31, 2018 | -38.16% |
| Sep 30, 2018 | -66.05% |
| Jun 30, 2018 | 143.77% |
| Mar 31, 2018 | 102.83% |
| Dec 31, 2017 | 389.86% |
| Sep 30, 2017 | 56.31% |
| Jun 30, 2017 | 251.89% |
| Mar 31, 2017 | 95.39% |
| Dec 31, 2016 | 52.45% |
| Sep 30, 2016 | 607.90% |
| Jun 30, 2016 | -31.20% |
| Mar 31, 2016 | 88.89% |
| Dec 31, 2015 | 9.18% |
| Sep 30, 2015 | 6.73% |
| Jun 30, 2015 | -32.33% |
| Mar 31, 2015 | 51.60% |
| Dec 31, 2014 | -71.38% |
| Sep 30, 2014 | -80.89% |
| Jun 30, 2014 | -34.21% |
| Mar 31, 2014 | -70.76% |
| Dec 31, 2013 | 36.93% |
| Sep 30, 2013 | 620.36% |
| Jun 30, 2013 | 537.72% |
| Mar 31, 2013 | 449.24% |
| Dec 31, 2012 | 370.28% |
| Sep 30, 2012 | -18.05% |
| Jun 30, 2012 | -54.80% |
| Mar 31, 2012 | 31.31% |
| Dec 31, 2011 | 18.80% |
| Sep 30, 2011 | 28.88% |
| Jun 30, 2011 | 47.48% |